Cite

HARVARD Citation

    Parveen, S. et al. (2021). Therapeutic targeting with DABIL‐4 depletes myeloid suppressor cells in 4T1 triple‐negative breast cancer model. Molecular oncology. 15 (5), pp. 1330-1344. [Online]. 
  
Back to record